Latest Data & Signals Issued

Signal Type Signal Value Data
Score -2.498 14 days ( 12.09 % )
Last Price $0.439 2.86 %
High/ Low $0.421 - $0.464 24.68%
Chg 7 Days 18.47 % $0.371 $0.439
Chg 30 Days -3.66 % $0.456 $0.439
Chg 12 mos -78.98 % $2.09 $0.439
Trend - 3 mos -6.66 % Width: 179.59 %
Trend - 12 mos -66.11 % Width: 380.42 %
Pred. range - 3 mos $0.253 - $0.707 -42.42 % - 60.99 %
Pred. range - 12 mos N/A - $0.233 -100.00 % - -47.06 %
Short MA avg 3 mos Buy Mar 10, 2025 - 5 days
Long MA avg 3 mos Sell Feb 24, 2025 - 15 days
Short/Long MA avg 3 mos Sell Feb 28, 2025 - 11 days
Short MA avg 12 mos Sell Feb 24, 2025 - 15 days
Long MA avg 12 mos Buy Mar 11, 2025 - 4 days
Short/Long MA avg 12 mos Buy Dec 19, 2024 - 57 days
Pivot Short Buy Feb 20, 2025 - 17 days
Bollinger Buy Jun 27, 2024 - 179 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!
ABOUT FIBROGEN
FibroGen
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ...
GOLDEN STAR
Ticker Change Signal Date
ALE
$65.32
0.490% Mar 12
AMED
$92.12
0.488% Mar 12
HESM
$40.63
3.59% Mar 11
HDB
$59.97
1.18% Feb 26
ML
$86.18
0.139% Feb 26

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE